BillionToOne, Inc. vs LABCORP HOLDINGS INC., two Medical Diagnostics stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where BLLN and LH diverge most: on ev/ebitda, BLLN reads 429.9 and LH reads 19.2; on fcf yield, BLLN reads 0.4% and LH reads 5.4%. The rest of the comparable metrics sit closer together. What LH's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | BLLN | LH |
|---|---|---|
| Price | $138.56 | $308.95 |
| Market cap | $7.3B | $25.6B |
| Sector | Medical Diagnostics | Medical Diagnostics |
| Stage | Growth | Mature |
| Implied growth (priced in) | — | +6.9% |
| P/E | — | 27.4 |
| P/B | 14.53 | 2.93 |
| P/S | 25.40 | 1.81 |
| EV/EBITDA | 429.9 | 19.2 |
| Revenue growth | +100.6% | +7.4% |
| Gross margin | 73.0% | 28.7% |
| Operating margin | 16.4% | 10.8% |
| Net margin | 1.7% | 6.7% |
| Return on equity | 0.9% | 10.8% |
| Return on assets | 0.7% | 4.9% |
| Return on invested capital | 2.0% | 7.5% |
| FCF yield | 0.4% | 5.4% |
| Dividend yield | — | 0.9% |
| Debt / equity | 0.18 | 0.73 |
| Current ratio | 10.92 | 1.73 |
| Altman Z (solvency) | 6.95 | 3.06 |
| Piotroski F (quality) | 5 / 9 | 4 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.